Rising HPV-Related Oral Cancers in Young Men Prompt Vaccination Expansion Calls
A leading Romanian oral and maxillofacial surgeon has highlighted a sharp increase in human papillomavirus (HPV)-related oral cancers among young men, urging expanded free vaccination access up to age 45, reported by Agerpres. Prof. Univ. Spiridon” Hospital, noted that approximately one in three tumors now test positive for HPV, a significant rise from previous decades.
Young Patients Rise in HPV-Driven Cases
Costan emphasized that the demographic profile of patients has shifted dramatically. “The number of young patients has risen sharply,” he said, citing that individuals aged 30–40 now comprise nearly half of cases, compared to older adults with smoking and alcohol histories. “HPV infection, often without traditional risk factors, is increasingly the root cause,” he added.
The surgeon’s remarks align with data from the Iași College of Dental Physicians, which organized the “OralOncoCheck” event to address the growing burden of HPV-driven oral cancers. According to Archyde, surgical teams at Iași’s hospital now perform three to four major oncological interventions weekly—a surge from two to three annual cases a decade ago.
Preventative Economics and Public Health Implications
Health officials are advocating for expanded vaccination programs to mitigate the rising incidence. Costan argued that extending free HPV vaccination to adults up to 45 could prevent costly surgical reconstructions and improve survival rates. “Prophylactic vaccination is far less expensive than managing advanced-stage cancers,” he stated, noting that early detection and intervention significantly enhance patient outcomes.
The clinical rationale hinges on cost-effectiveness. Agerpres reported that HPV-related oral cancers now account for a growing share of upper aerodigestive tract malignancies, with the World Health Organization (WHO) highlighting the role of HPV in these cancers.
Early Detection and Public Awareness
Costan stressed the importance of early screening, warning that persistent oral lesions—whether nodular or ulcerative—require immediate medical evaluation. “Many patients delay care because symptoms are absent in early stages,” he said. “Early intervention can prevent disfiguring surgeries and improve quality of life.”
The Iași event highlighted the role of dentists and oral surgeons as frontline screeners, with guidelines urging prompt referral for biopsies. “Patients who undergo early treatment often regain full functionality without visible signs of their cancer,” Costan noted.
FAQ
HPV, a sexually transmitted virus, is increasingly linked to oropharyngeal cancers. Traditional risk factors like smoking and alcohol are less prevalent among new cases, with HPV infection—often asymptomatic—emerging as the primary driver.
Vaccination is highly effective against oncogenic HPV strains. Studies show it reduces the risk of HPV-related cancers when administered before exposure. Expanding access to adults could further curb transmission and reduce disease burden.
Treating advanced HPV-positive oral cancers involves complex surgeries, radiation, and long-term care, costing tens of thousands of euros per patient. Vaccination, by contrast, is relatively inexpensive and prevents disease before it develops.
Context and Next Steps
The call for expanded vaccination comes as Romania’s healthcare system grapples with rising cancer rates. The National Cancer Registry reported an increase in oral cancer diagnoses over five years. Public health advocates are now pushing for policy changes to align with recommendations from the European Cancer Organization, which supports HPV vaccination for adults in high-risk groups.
Costan’s remarks highlight a broader global trend: the WHO has classified HPV as a key driver of several cancers, including those of the mouth and throat, and is urging member states to prioritize vaccination and screening. As the Iași event demonstrated, early detection and prevention remain critical in curbing this evolving public health challenge.